Conference Magazine - GoingPublic.de - Deutsches Eigenkapitalforum

Capital Seeking Companies
Profile
Founded in 2006
Number of employees 19
Equity (in EUR million) 0.053
Financing needs (in EUR million) 2
Positiv result from 2012
Revenues in 2010 (in EUR million) 0.24
Revenues in 2011 (in EUR million) 0.82
Revenues in 2012: (e) (in EUR million) 2.00
Revenues in 2013: (e) (in EUR million) 3.70
Contact
Contact person Dr. Alexander Wolter
Phone +49-(0) 3 51-21 24 96-10
E-mail alexander.wolter@hiperscan.com
Website www.hiperscan.com
Address Weißeritzstr. 3
01067 Dresden
Germany
Executive partners: Dr. Alexander Wolter (left), Dr. Stefan Friedrichowski
Page 144 Deutsches Eigenkapitalforum 2012
HiperScan GmbH
Technology / electronic
components and hardware
Business field
HiperScan is a manufacturer of analytical devices that identify
chemical compounds and determine concentrations in
mixtures. Currently, we are concentrating on the needs of
German pharmacists. Our devices allow them to fulfil the
European directives in the simplest way.
We work with near-infrared (NIR) spectroscopy. This means
that we expose a sample to light, collect the scattered light
and extract chemical information on the molecules.
NIR spectroscopy is an established method in many industry
branches, but it used to be expensive and complex. We
take NIR away from specialised laboratories and into the
field, putting it into the hands of the staff on site.
Strategic market position
We have become the market leader for analytical systems
in pharmacies for the following reasons:
- We have the only device with an acceptable price (due to
technology with a patented MEMS chip)
- We offer comprehensive databases (fee-based)
- We deliver the simplest possible work flow
- We deploy a specialised sales force
Management
Executive partners: Dr. Alexander Wolter (founder and
formerly a scientist with the Fraunhofer Society) and
Dr. Stefan Friedrichowski (formerly worked for Carl Zeiss)
Planned investment, shareholders/investors
Our investors are HTGF, Bonn (2008) and TGFS, Leipzig
(2010). We have been profitable since mid-2012.
In order to launch our technology on other markets, we have
to undergo the preparation stages before we actually enter
these markets. We are planning for regional expansion, as
well as occupying other branches (the foodstuffs, agricultural,
pharmaceutical and logistics sectors are the most
promising).